528 related articles for article (PubMed ID: 33812967)
1. Design of liposomes as drug delivery system for therapeutic applications.
Guimarães D; Cavaco-Paulo A; Nogueira E
Int J Pharm; 2021 May; 601():120571. PubMed ID: 33812967
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of liposome formulation parameters and their influence on encapsulation, stability and drug release in glibenclamide liposomes.
Maritim S; Boulas P; Lin Y
Int J Pharm; 2021 Jan; 592():120051. PubMed ID: 33161039
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of cefditoren pivoxil-loaded liposomes for controlled in vitro and in vivo drug release.
Venugopalarao G; Lakshmipathy R; Sarada NC
Int J Nanomedicine; 2015; 10 Suppl 1(Suppl 1):149-57. PubMed ID: 26491316
[TBL] [Abstract][Full Text] [Related]
4. Liposome-based delivery system for vaccine candidates: constructing an effective formulation.
Giddam AK; Zaman M; Skwarczynski M; Toth I
Nanomedicine (Lond); 2012 Dec; 7(12):1877-93. PubMed ID: 23249332
[TBL] [Abstract][Full Text] [Related]
5. Mechanism and kinetics of the loss of poorly soluble drugs from liposomal carriers studied by a novel flow field-flow fractionation-based drug release-/transfer-assay.
Hinna AH; Hupfeld S; Kuntsche J; Bauer-Brandl A; Brandl M
J Control Release; 2016 Jun; 232():228-37. PubMed ID: 27112112
[TBL] [Abstract][Full Text] [Related]
6. Liposomes for drug delivery: review of vesicular composition, factors affecting drug release and drug loading in liposomes.
Pande S
Artif Cells Nanomed Biotechnol; 2023 Dec; 51(1):428-440. PubMed ID: 37594208
[TBL] [Abstract][Full Text] [Related]
7. Liposomal antibiotics for the treatment of infectious diseases.
Alhariri M; Azghani A; Omri A
Expert Opin Drug Deliv; 2013 Nov; 10(11):1515-32. PubMed ID: 23886421
[TBL] [Abstract][Full Text] [Related]
8. Advances and Challenges of Liposome Assisted Drug Delivery.
Sercombe L; Veerati T; Moheimani F; Wu SY; Sood AK; Hua S
Front Pharmacol; 2015; 6():286. PubMed ID: 26648870
[TBL] [Abstract][Full Text] [Related]
9. Approaches to Address PK-PD Challenges of Conventional Liposome Formulation with Special Reference to Cancer, Alzheimer's, Diabetes, and Glaucoma: An Update on Modified Liposomal Drug Delivery System.
Kesharwani P; Kumari K; Gururani R; Jain S; Sharma S
Curr Drug Metab; 2022; 23(9):678-692. PubMed ID: 35692131
[TBL] [Abstract][Full Text] [Related]
10. [In Vitro Release Method for Liposome Drug Products].
Yamamoto E
Yakugaku Zasshi; 2019; 139(2):249-254. PubMed ID: 30713235
[TBL] [Abstract][Full Text] [Related]
11. Liposomes for Antibiotic Encapsulation and Delivery.
Gonzalez Gomez A; Hosseinidoust Z
ACS Infect Dis; 2020 May; 6(5):896-908. PubMed ID: 32208673
[TBL] [Abstract][Full Text] [Related]
12. Liposomal drug delivery systems: an update review.
Samad A; Sultana Y; Aqil M
Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
[TBL] [Abstract][Full Text] [Related]
13. A review on multivesicular liposomes for pharmaceutical applications: preparation, characterization, and translational challenges.
Chaurasiya A; Gorajiya A; Panchal K; Katke S; Singh AK
Drug Deliv Transl Res; 2022 Jul; 12(7):1569-1587. PubMed ID: 34599471
[TBL] [Abstract][Full Text] [Related]
14. Aromatized liposomes for sustained drug delivery.
Li Y; Ji T; Torre M; Shao R; Zheng Y; Wang D; Li X; Liu A; Zhang W; Deng X; Yan R; Kohane DS
Nat Commun; 2023 Oct; 14(1):6659. PubMed ID: 37863880
[TBL] [Abstract][Full Text] [Related]
15. Liposomal doxorubicin as targeted delivery platform: Current trends in surface functionalization.
Makwana V; Karanjia J; Haselhorst T; Anoopkumar-Dukie S; Rudrawar S
Int J Pharm; 2021 Jan; 593():120117. PubMed ID: 33259901
[TBL] [Abstract][Full Text] [Related]
16. Analytical characterization of liposomes and other lipid nanoparticles for drug delivery.
Fan Y; Marioli M; Zhang K
J Pharm Biomed Anal; 2021 Jan; 192():113642. PubMed ID: 33011580
[TBL] [Abstract][Full Text] [Related]
17. Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity.
Teymouri M; Badiee A; Golmohammadzadeh S; Sadri K; Akhtari J; Mellat M; Nikpoor AR; Jaafari MR
Int J Pharm; 2016 Sep; 511(1):236-244. PubMed ID: 27363937
[TBL] [Abstract][Full Text] [Related]
18. Radiolabeled Tedizolid Phosphate Liposomes for Topical Application: Design, Characterization, and Evaluation of Cellular Binding Capacity.
Karpuz M; Atlihan-Gundogdu E; Demir ES; Senyigit Z
AAPS PharmSciTech; 2021 Feb; 22(2):62. PubMed ID: 33528714
[TBL] [Abstract][Full Text] [Related]
19. Liposomal pemetrexed: formulation, characterization and in vitro cytotoxicity studies for effective management of malignant pleural mesothelioma.
Essam Eldin N; Elnahas HM; Mahdy MA; Ishida T
Biol Pharm Bull; 2015; 38(3):461-9. PubMed ID: 25757929
[TBL] [Abstract][Full Text] [Related]
20. Preparation of liposomal amiodarone and investigation of its cardiomyocyte-targeting ability in cardiac radiofrequency ablation rat model.
Zhuge Y; Zheng ZF; Xie MQ; Li L; Wang F; Gao F
Int J Nanomedicine; 2016; 11():2359-67. PubMed ID: 27313453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
